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ABSTRACT 
 
Objectives: Reporting peritonitis as a complication to a patient holding copper IUD for 9 years, 
this ended in hysterectomy. Method: Reporting the case of a patient who was hospitalized and 
operated in gynecology at “Queen Geraldine” Hospital, Tirana. Results: Patient with high 
temperature of 39.5˚C, pain at the end of the abdomen with moderate intensity, with no 
accompanying illnesses. After ambulatory treatment with antipyretics, the complaints 
persisted. In this situation she was addressed to the gynecological service, “Queen Geraldine” 
Hospital, Tirana. In the history of the patient, she has had around 9 years since she has placed 
copper IUD and repeated unrecognized vaginal infections.  
 
The ultrasound examination showed: uterus with size 86 x 53 x 56mm. The IUD was found in 
the cavity in a normal position, an admixed mass with a size of 66 x 55 mm of dishomogeneous 
content. At the Douglas level, stretching to the right adjective, a hypoecogeneous piriform mass 
is found in favor of a pyosalpingitis. In the hemogram obtained a leukocytosis of 22.37 x 10 * 
9/L, granulocytes 20.68 x 10 * 9/L, HGB 9.4 g/dl. In the vaginal examination, the uterus was 
included with a massive conglomerate occupying the whole of Douglas and tamponized by 
intestines, dolent, with fluctuation. Affiliates included in this conglomerate. Parameters sore, 
infiltrated.  
 
The patient underwent antibiotic therapy for 7 days, improving the situation of complaints and 
preparing for intervention. Conclusions: The patient underwent supravaginalhysterectomy and 
bilateralsalpingooophorectomy, a peritoneal wash, after the peritoneal generalization was 
found. Postoperative deafness of the patient, with early placement of peristalsis and significant 
improvement of the clinical staff. Antibiotic prophylaxis at the time of IUD placement, patient 
explanation for its complications, and correct tracking over the years are important in 
preventing these severe situations. It is also worth emphasizing the importance of accurate 
diagnosis and timely intervention in chronic SIP or generalized peritonitis.   
Recommendations: Proper timely screening and treatment of vaginal infections in IUDcarriers 
prevents pelvic inflammatory disease and consequently severe peritoneal complications.  
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1. Introduction 
Peritonitisis defined as an inflammation of the serous membranes that extends into 
the abdominal cavity and the organs in it. It can present as a complication of pelvic 
inflammatory disease (infectious and inflammatory disorder of the female genital 
tract including the uterus, fallopian tubes and surrounding structures).In pelvic 
inflamatory disease ascendant infection from the vagina and cervix passes into the 
upper genital tract. The most common causes are: N. gonorrheae, Chlamydia 
trachomatis, Gardnerellavaginalis, Mycoplasma hominis, Ureaplasmaurealyticum, 
Hemophilus influenza, Anaerobes such as peptococcus and bacteroides. Risk 
Factorsinclude: young women, multipartneriteti, IUD (2-9 times increase in risk for 
PID), unprotected sexual intercourse.  
 
2. Objectives 
Reporting peritonitis as a complication to a patient holding copper IUD for 9 years, 
which ended in hysterectomy. 
3. Method 
Reporting the case of a patient who was hospitalized and operated in gynecology 
department in “Queen Geraldine” Hospital, Tirana. 
 
4. Anamnesis 
The 44-year-old patient presents to the emergency gynecological service at the Queen 
Geraldine, with high temperature, 39.5 C, abdominal pain in one week, refers to a 
spontaneous hemorrhage 3 weeks ago, IUD for 9 years.  
Obstetric-Gynecological Anamnesis: 2 s/cesarean births,1 abortion, repeated bacterial 
vaginosis. 
Anamnesis of life: tonsillectomy. After ambulatory treatment with antipyretics, the 
complaints persisted.The ultrasound examination showed: uterus with size 
86x53x56mm. The IUD was found in the cavity in a normal position, an admixed mass 
with a size of 66 x 55 mm of dishomogeneous content. At the Douglas level, stretching 
to the right adjective, a hypoecogeneouspiriform mass was found in favor of a 
pyosalpingitis.  
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In the hemogram obtained a leukocytosis of 22.37x10 * 9 / L, granulocytes 20.68x10 * 
9/L, HGB 9.4 g / dl. In the vaginal examination, the uterus was included with a massive 
conglomerate occupying the whole of Douglas and tamponized by intestines, dolent, 
with fluctuation. Affiliates included in this conglomerate. Parameters sore, infiltrated. 
 
5. Results 
The patient underwent systemic antibiotic therapy for 7 days, improving the situation 
of complaints and preparing for intervention.In laparatomy was found a conglomerate 
of uterus with radix mesentery, illeum, adnexes adhered to the lateral walls of the 
pelvis.Aderentiolysis was performed, bilateral pyosalpings where thick, green pus was 
aspirated. The patient underwent supravaginal hysterectomy and bilateral salpingo-
oophorectomy, a peritoneal wash, after the peritoneal generalization was found. 
Postoperative deafness of the patient, with early placement of peristalsis and 
significant improvement of the clinical staff. 
 
6. Conclusions 
 
Antibiotic prophylaxis at the time of IUD placement, patient explanation for its 
complications, and correct tracking over the years are important in preventing these 
severe situations. It is also worth emphasizing the importance of accurate diagnosis 
and timely intervention in chronic SIP or generalized peritonitis. 
 
7. Recommendations 
 
Proper timely screening and treatment of vaginal infections in IUD carriers prevents 
pelvic inflammatory disease and consequently severe peritoneal complications. 
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